Unlike rreahard, I asked Paul for an introduction to BioAgra shortly after the JV was completed. I was clear that my intent is to visit the facilities and staff.

Though facilty development is being worked on agressively at this time, I was asked to wait until November so that I could see how production would flow and the facility would be close to being complete.

I respected that request to wait until November and after Paul`s introduction to Neal, I talked with Neal and committed to a mid November visit for myself and another investor.

I found Neal to be a driven man who wanted strongly to get beta-glucan to market. I look forward to meeting him in person. My first impression is that he has the power on several levels to make this company work and be profitable.

Many people have scoffed at my tenacity in holding and accumulating NPCT for over seven years. Tenacity can be a foible or virtue.

In this instance, I expect it to be a virtue. More so, the tenacity of NPCT is far more important. They have shown the tenacity to keep the doors open when many MANY people would have closed the doors years ago.

It is with that thought and the potential of BioAgra (and also Exypnotech) that I remain tenacious and will take the time to visit BioAgra.

And I expect to be profitable in my own investment in this company.

Kent